As precision medicine redefines treatment standards, traditional HEOR models struggle to keep up. This article explores how the healthcare industry can rethink value frameworks to better capture the benefits of individualized therapies like Herceptin and Keytruda, from biomarkers to long-term outcomes.
Take the Next Step
1
2
3
Explore Suppliers
Browse trusted partners with relevant expertise
Review Capabilities
Compare services, experience, and past work
Start Your Project
Connect and begin collaborating
.jpg)